Accrued liabilities consist of the following (in thousands):
March 31,
December 31,
2026
2025
Accrued research and development-related expenses
$
1,311
1,650
Accrued clinical trial-related expenses
222
268
Accrued professional services expenses
103
84
Accrued offering costs
75
—
Other
56
50
Total accrued liabilities
1,767
2,052
No definition available.
Tabular disclosure of the components of accrued liabilities.